As per the recently published report by MarketsandMarket?, The report "Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Research Area, Technology (NGS, PCR, Mass Spectrometry), Disease (Cancer, Infectious), Application (Diagnostics, Clinical Research) - Global Forecast to 2029", is expected to reach USD 93.8 billion in 2029 from USD 57.7 billion in 2024, at a CAGR of 10.2% during the forecast period.
- 696??Market Data Tables
- 54? ??Figures
- 532??Pages and in-depth TOC on?" Biomarkers Market - Global Forecast to 2029”
Some of the prominent key players are:
- F. Hoffmann-La Roche Ltd. (Switzerland),
- Thermo Fisher Scientific Inc. (US),
- Abbott Laboratories (US),
- QIAGEN N.V. (Netherlands),
- PerkinElmer, Inc. (US),
- Merck KGaA (Germany) and many more......
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Biomarkers Market.
- By product & service, the biomarkers market is categorized into consumables, services, and software. The consumables are further sub-segmented into assay kits, reagents & chemicals, columns & filters. The consumables accounted for the largest share of the global biomarkers market in 2023.
- By type, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. The efficacy biomarkers are subsegmented into predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, and prognostic biomarkers.
- Based on technology, the biomarkers market has been segmented into immunoassays, NGS, PCR, mass spectrometry, chromatography, and other technologies. The immunoassay technology is subsegmented into ELISA, western blot, and protein microarray. In 2023, the immunoassays segment accounted for the largest share of the biomarkers market.
- Based on the disease indication, the biomarkers market is segmented into cancer, infectious diseases, immunological disorders, neurological disorders, cardiovascular disorders, and other disease indications. In 2023, cancer accounted for the largest share of the biomarkers market.?
- The biomarkers market is segmented into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. The North America region is witnessing increasing investments and research activities in the field of drug discovery.
The major factors driving the growth of this market include the growing importance of companion diagnostics, the increase in the global prevalence of cancer, and the growing importance of biomarkers for rare conditions.
